|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 90.15 USD | +1.29% |
|
+2.14% | +3.25% |
| Feb. 17 | Globus Medical Insider Sold Shares Worth $876,700, According to a Recent SEC Filing | MT |
| Jan. 30 | Needham Upgrades Globus Medical to Buy From Hold, Sets $112 Price Target | MT |
| Capitalization | 12.07B 10.21B 9.31B 8.91B 16.5B 1,094B 17.07B 109B 43.01B 528B 45.25B 44.32B 1,863B | P/E ratio 2025 * |
22.8x | P/E ratio 2026 * | 25.1x |
|---|---|---|---|---|---|
| Enterprise value | 11.45B 9.69B 8.84B 8.45B 15.66B 1,039B 16.2B 103B 40.82B 501B 42.94B 42.06B 1,768B | EV / Sales 2025 * |
3.93x | EV / Sales 2026 * | 3.49x |
| Free-Float |
82.69% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Globus Medical, Inc.
| 1 day | +1.29% | ||
| 1 week | +2.14% | ||
| Current month | -0.58% | ||
| 1 month | -3.55% | ||
| 3 months | +8.07% | ||
| 6 months | +49.63% | ||
| Current year | +3.25% |
| 1 week | 87.27 |  | 91 |
| 1 month | 86.01 | | 95.22 |
| Current year | 85.65 | | 101.4 |
| 1 year | 51.79 | | 101.4 |
| 3 years | 43.38 | | 101.4 |
| 5 years | 43.38 | | 101.4 |
| 10 years | 19.25 | | 101.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Keith Pfeil
CEO | Chief Executive Officer | 47 | 2025-07-17 |
Kyle Kline
DFI | Director of Finance/CFO | 41 | 2025-07-17 |
Brian Kearns
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Paul
CHM | Chairman | 59 | 2003-02-28 |
David Davidar
BRD | Director/Board Member | 60 | 2003-02-28 |
Daniel Lemaitre
BRD | Director/Board Member | 72 | 2011-04-20 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 1.01% | 2 M€ | |
| +6.16% | 0.99% | 147 M€ | |
| -.--% | 0.44% | 4 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.29% | +2.14% | +6.27% | +49.80% | 11.91B | |
| +0.92% | -0.26% | -12.97% | +6.14% | 195B | |
| +2.16% | -2.56% | +14.43% | +16.14% | 124B | |
| +0.07% | -1.50% | +49.20% | +123.07% | 70.03B | |
| +0.89% | -3.88% | +47.35% | +103.99% | 60.35B | |
| +2.99% | +1.14% | -18.86% | -25.29% | 50.51B | |
| +3.36% | +5.93% | - | - | 38.41B | |
| +3.37% | +6.82% | -19.58% | -36.56% | 27.11B | |
| +1.61% | +2.42% | +13.52% | +31.47% | 24.07B | |
| +2.61% | -1.90% | -16.06% | -47.04% | 19.64B | |
| Average | +1.93% | +1.22% | +7.03% | +24.64% | 62.08B | |
| Weighted average by Cap. | +1.58% | +0.05% | +7.13% | +27.89% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.91B 2.47B 2.25B 2.15B 3.98B 264B 4.12B 26.21B 10.38B 127B 10.93B 10.7B 450B | 3.16B 2.68B 2.44B 2.33B 4.32B 287B 4.47B 28.46B 11.27B 138B 11.86B 11.62B 488B |
| Net income | 541M 458M 418M 400M 740M 49.1B 766M 4.87B 1.93B 23.69B 2.03B 1.99B 83.56B | 491M 416M 379M 362M 671M 44.54B 695M 4.42B 1.75B 21.49B 1.84B 1.8B 75.8B |
| Net Debt | -615M -520M -475M -454M -841M -55.78B -870M -5.53B -2.19B -26.91B -2.31B -2.26B -94.93B | -1.03B -873M -797M -762M -1.41B -93.59B -1.46B -9.28B -3.68B -45.15B -3.87B -3.79B -159B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-18 | 90.15 $ | +1.29% | 1,402,574 |
| 26-02-17 | 89.00 $ | +1.03% | 782,778 |
| 26-02-13 | 88.09 $ | +1.00% | 836,779 |
| 26-02-12 | 87.22 $ | -1.18% | 762,485 |
| 26-02-11 | 88.26 $ | -0.52% | 720,199 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GMED Stock
Select your edition
All financial news and data tailored to specific country editions
